- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
BAP1 promotes osteoclast function by metabolic reprogramming ; volume:14 ; number:1 ; day:22 ; month:9 ; year:2023 ; pages:1-16 ; date:12.2023
Nature Communications ; 14, Heft 1 (22.9.2023), 1-16, 12.2023
- Creator
-
Rohatgi, Nidhi
Zou, Wei
Li, Yongjia
Cho, Kevin
Collins, Patrick L.
Tycksen, Eric
Pandey, Gaurav
DeSelm, Carl J.
Patti, Gary J.
Dey, Anwesha
Teitelbaum, Steven L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-41629-4
- URN
-
urn:nbn:de:101:1-2024013121090643590034
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rohatgi, Nidhi
- Zou, Wei
- Li, Yongjia
- Cho, Kevin
- Collins, Patrick L.
- Tycksen, Eric
- Pandey, Gaurav
- DeSelm, Carl J.
- Patti, Gary J.
- Dey, Anwesha
- Teitelbaum, Steven L.
- SpringerLink (Online service)
Other Objects (12)
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
Glycobiology in osteoclast differentiation and function
PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming
PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
IDH2 stabilizes HIF ‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
Metabolic reprogramming in macrophage responses
PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
Glycobiology in osteoclast differentiation and function
PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming
PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
IDH2 stabilizes HIF ‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
Metabolic reprogramming in macrophage responses
PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming
KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc
Glycobiology in osteoclast differentiation and function
PDK4 promotes vascular calcification by interfering with autophagic activity and metabolic reprogramming
PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
IDH2 stabilizes HIF ‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
Metabolic reprogramming in macrophage responses
PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis